Neovasc

Neovasc is a specialized medical device company dedicated to developing, manufacturing, and marketing products for the rapidly growing cardiovascular market. Its product portfolio includes the Tiara™ technology, which is under development for transcatheter treatment of mitral valve disease, the Neovasc Reducer™ for treating refractory angina, and a range of advanced biological tissue products that are used as critical components in third-party medical products, including transcatheter heart valves.